Latest Breaking News On - Brigitte loenders - Page 1 : vimarsana.com

ZUG, Switzerland, May 06, 2023 Pharvaris , a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema attacks, today announced. | May 6, 2023

United statesUnited kingdomAnna valerievaRemys petersonAnne lesageHenriette farkasBrigitte loendersMarcus maurerPeng luMarca riedlGlobenewswire incEuropean unionEarly developmentExchange commissionAngioedema workshopChief medical officer